| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $436.2M | +78.3% |
| Cost of Revenue | $320.1M | +65.7% |
| Gross Profit | $116.1M | +125.9% |
| R&D Expense | $174.4M | +46.5% |
| SG&A Expense | $131.6M | +19.3% |
| Operating Income | -$189.8M | -6.7% |
| Pre-tax Income | -$189.4M | -5.9% |
| Income Tax | $764K | -79.1% |
| Net Income | -$190.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $271.0M | +66.8% |
| Short-term Investments | $147.9M | +79.9% |
| Accounts Receivable | $36.4M | +3.6% |
| Inventory | $119.1M | +10.4% |
| Current Assets | $692.6M | +45.3% |
| Total Assets | $1.18B | +25.8% |
| Current Liabilities | $339.5M | +52.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.9M | +50.5% |
| Capital Expenditures | $67.1M | +22.6% |
| Investing Cash Flow | -$98.3M | -918.2% |
| Financing Cash Flow | $256.7M | +3383.3% |
| Free Cash Flow | -$116.0M | +24.5% |
| -4.2% |
| EPS (Basic) | -$0.38 | +0.0% |
| EPS (Diluted) | -$0.38 | +0.0% |
| Long-term Debt |
| $345.4M |
| +214.0% |
| Total Liabilities | $801.9M | +107.4% |
| Stockholders' Equity | $382.5M | -31.0% |